Onychomycosis in older adults: The age and associated factors affecting the complete cure rate

被引:8
作者
Bunyaratavej, Sumanas [1 ]
Srinonprasert, Varalak [2 ]
Kiratiwongwan, Rungsima [1 ]
Wongdama, Supisara [1 ]
Leeyaphan, Charussri [1 ]
机构
[1] Mahidol Univ, Siriraj Hosp, Dept Dermatol, Fac Med, 2 Wanglang Rd, Bangkok 10700, Thailand
[2] Mahidol Univ, Siriraj Hosp, Fac Med, Div Geriatr Med,Dept Med, Bangkok, Thailand
关键词
complete cure; cut-off age; older adults; onychomycosis; risk factors; TOENAIL ONYCHOMYCOSIS;
D O I
10.1111/ajd.13686
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Limited studies exist on the factors associated with a complete cure of onychomycosis in older adults. Objectives: To determine the age and factors associated with a complete cure among older adults diagnosed with toenail onychomycosis. Methods: A retrospective cohort study was conducted of 95 older adult patients (aged >= 60 years) diagnosed with toenail onychomycosis between January 2016 and December 2017. Demographic data, mycological findings, treatments and durations to a complete cure were reviewed. Results: The complete cure rates of the patients aged < 70 years and >= 70 years were 67.4% and 44.9%, respectively (P = 0.027). Patients aged >= 70 years were significantly higher in male gender, had higher history of smoking, peripheral arterial disease, impaired renal function, antihypertensive drug and amorolfine nail lacquer usage, and polypharmacy. A multivariate analysis revealed that being aged >= 70 years and having a nail thickness >2 mm were associated with failure to achieve a complete cure. The median times to a complete cure for older adults aged <70 years and >= 70 years were 20 months and 47 months, respectively (P = 0.007). Conclusions: An age >= 70 years was related to a lower cure rate and delays in achieving a complete cure. A nail thickness > 2 mm was a poor prognostic factor for a complete cure. Moreover, very old adults were more likely to suffer side effects arising from the use of systemic antifungal medications.
引用
收藏
页码:74 / 80
页数:7
相关论文
共 30 条
[21]   Onychomycosis in clinical practice: factors contributing to recurrence [J].
Scher, RK ;
Baran, R .
BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 :5-9
[22]   An open comparative study of nail drilling as adjunctive treatment for toenail onychomycosis [J].
Shemer, A. ;
Gupta, A. K. ;
Amichai, B. ;
Farhi, R. ;
Baran, R. ;
Daniel, C. R., III ;
Daigle, D. ;
Foley, K. A. .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2016, 27 (05) :480-483
[24]   Frailty index to predict all-cause mortality in Thai community-dwelling older population: A result from a National Health Examination Survey cohort [J].
Srinonprasert, V. ;
Chalermsri, C. ;
Aekplakorn, W. .
ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2018, 77 :124-128
[25]  
Tavakkol Amir, 2006, Am J Geriatr Pharmacother, V4, P1, DOI 10.1016/j.amjopharm.2005.12.012
[26]  
TGRI, SIT THAI ELD 2014
[27]   Toenail onychomycosis: an important global disease burden [J].
Thomas, J. ;
Jacobson, G. A. ;
Narkowicz, C. K. ;
Peterson, G. M. ;
Burnet, H. ;
Sharpe, C. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (05) :497-519
[28]   Onychomycosis Evaluation, Treatment Options, Managing Recurrence, and Patient Outcomes [J].
Vlahovic, Tracey C. .
CLINICS IN PODIATRIC MEDICINE AND SURGERY, 2016, 33 (03) :305-+
[29]  
Westerberg DP, 2013, AM FAM PHYSICIAN, V88, P762
[30]  
Wimoolchart Saranjit, 2018, Indian Dermatol Online J, V9, P271, DOI 10.4103/idoj.IDOJ_208_17